In the murine model of AD, the expression of lncRNA MALAT1 is upregulated in the skin, and its knockdown represses NLRP3 inflammasome activation and mitigates Th1/Th2 imbalance, thus potentially ameliorating AD [129]. This evidence concerns the gene NLRP3 and Alzheimer disease.